Abvc Biopharma (ABVC) Dividends payables (2011 - 2012)
Abvc Biopharma's (ABVC) quarterly Dividends payables came in at $1116.0 in Q2 2012, down 96.46% quarter-over-quarter from $31566.0 in Q3 2011.
Powered by 
Analysis
Abvc Biopharma (ABVC) Dividends payables (2011 - 2012) Analysis & Trends
Abvc Biopharma (ABVC) has reported Dividends payables for 2 consecutive years, with $1116.0 the latest figure, recorded in Q2 2012.
- For the quarter ending Q2 2012, Dividends payables changed N/A year-over-year to $1116.0; the trailing twelve-month figure through Jun 2012 stood at $1116.0 (changed N/A YoY), and the FY2011 full-year result was $31566.0, changed N/A from the prior year.
- Dividends payables slipped to $1116.0 in Q2 2012 per ABVC's latest filing, from $31566.0 in the prior quarter.
- Across five years, Dividends payables topped out at $31566.0 in Q3 2011 and bottomed at $1116.0 in Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | - |